In endometrial cancer, the MLH1-/PMS2- pattern was observed in 69.2% of the cases, followed by MSH2-/MSH6- (23.1%), PMS2- (3.8%), and MSH6- (3.8%). This evidence concerns the gene MSH2 and endometrial cancer.